Rinvoq (Upadacitinib)

**Product type:** Human Prescription Drug

**Active ingredient:** UPADACITINIB

**Strength:** 1 mg/mL

**Dosage form:** Solution

**Route:** Oral

**Labeler:** AbbVie Inc.

**Marketing category:** NDA (NDA218347)

**Pharmacologic class:** Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]